Malignant colon neoplasm

Related records

Broader conditions (19)

• Cancer
• Cancer or benign tumor
• Colonic disorder
• Colonic neoplasm
• Colorectal cancer
• Colorectal neoplasm
• Digestive system cancer
• Digestive system disorder
• Digestive system neoplasm
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Human disease
• Intestinal cancer
• Intestinal disorder
• Intestinal neoplasm
• Large intestine disorder
• Neoplasm
• Neoplastic disease or syndrome

Narrower conditions (39)

• Adenosquamous colon carcinoma
• Appendix adenocarcinoma
• Appendix cancer
• Appendix carcinoma
• Appendix lymphoma
• Appendix mucinous cystadenocarcinoma
• Ascending colon cancer
• Carcinoma in situ of appendix
• Carcinoma in situ of cecum
• Cecum adenocarcinoma
• Cecum cancer
• Cecum carcinoma
• Cecum lymphoma
• Colon adenocarcinoma
• Colon Burkitt lymphoma
• Colon carcinoma
• Colon carcinoma in situ
• Colon Kaposi sarcoma
• Colon leiomyosarcoma
• Colon lymphoma

Trials (910)

• "Ultra" Enhanced Recovery After Surgery (E.R.A.S.) in Laparoscopic Colectomy for Cancer
• 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
• 18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer
• A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition
• A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
• A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
• A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
• A Clinico-biological Database in Cachexia in Patients With Colon Cancer
• A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study
• A Digimed Oncology PharmacoTherapy Registry
• A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
• A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
• A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer
• A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy
• A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth
• A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
• A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
• A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies
• A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Approved drugs (4)

• Bevacizumab
• Capecitabine
• Leucovorin sodium
• Levamisole

Drugs in development (197)

• Adakitug Phase 2
• Aflibercept Phase 2
• Aldesleukin Phase 1
• Aminolevulinic acid Phase 1
• Aminolevulinic acid hydrochloride Phase 1
• Anpocogin Phase 1
• Antineoplaston A10 Phase 2
• Arfolitixorin Phase 1
• Ascorbic acid Phase 1
• Aspirin Phase 3
• Atezolizumab Phase 2
• Avelumab Phase 3
• Azacitidine Phase 2
• BB-1701 Phase 1
• BCG LIVE Phase 3
• BCG vaccine Phase 3
• Binimetinib Phase 1
• Bortezomib Phase 1
• Bromelains Phase 2
• Bryostatin 1 Phase 1

Other linked drugs (4)

• Ferric carboxymaltose
• Mifepristone
• Ropivacaine
• Tinzaparin